OMP is looking to trade as "OMPI" on the Nasdaq. Listed as a day-to-day possibility is biotech company Xenogen, which has been on deck since mid-January. "If they don't make it this week they will probably be pulled off the calendar …
“It is our opinion, along with that of many other market professionals, that this current market is overbought. An overbought market often searches for a place, or more to the point, a reason to pull This is why fear in the markets should create …
We’ll see if any real solid news comes out confirming or denying the talk out there. Until then, it’s just another stock moving on rumors.
Fibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, …
We expect that when they get approval, doctors will use PLX cells for any number of lung disorders that don't have proper medication ... there is always risk in any stock. Share price could linger or lose steam if the management team fails to …
Affymax Inc. (NASDAQ: AFFY) has been in more than trouble. Its very future is at stake as far as investors (and speculators) are concerned. The company is restructuring, but this ... Read Full Story »
Dec 20 (Reuters) - BIOCORP PRODUCTION SA ::BIOCORP RECEIVES CE MARK APPROVAL FOR ITS SMART CAP EASYLOG.MARKET LAUNCH IS PLANNED FOR 2018 THROUGH PARTNERSHIPS.CE MARK FOR VERSION …